Ginger and cholesterol: LDL -17 mg/dL and documented hepatic mechanism

Ginger and cholesterol: data from the meta-analysis

Cardiovascular diseases are the leading cause of death worldwide. LDL cholesterol is a modifiable risk factor, and ginger shows significant effects documented by meta-analysis.

LDL -17 mg/dL: the meta-analysis

Mazidi et al. (2016), in Lipids in Health and Disease, analyzed clinical trials on ginger and lipid profile:

• LDL: -17 mg/dL (significant)
• Total cholesterol: -13 mg/dL
• Triglycerides: -10 mg/dL
• Doses: 2-4g/day for 8-12 weeks

Dual hepatic mechanism

Mechanism	Target	Effect	Source
HMG-CoA reductase inhibition	Cholesterol synthesis	↓ Hepatic LDL production	Fuhrman et al., 2000
Choleresis	Bile excretion	+62% bile (cholesterol evacuation)	Rasyid et al., 1999
AMPK activation	Lipid metabolism	↑ Oxidation of fatty acids	Misawa et al., 2015
NF-κB inhibition	Vascular inflammation	↓ LDL oxidation	Grzanna et al., 2005

Ginger vs statins: perspective

Approach	LDL reduction	Side effects	Role
Statins	-60 to -100 mg/dL	Myalgia, hepatotoxicity	Main treatment
Ginger	-17 mg/dL	Minimal	Supplement/prevention
Mediterranean diet	-10 to -20 mg/dL	None	Basis
Exercise	-5 to -10 mg/dL	None	Basis

The sugar trap on cholesterol

Fructose (50% of table sugar) is metabolized by the liver and converted to triglycerides. A shot with 34g sugar/100ml:

• Increases the synthesis of VLDL (precursor of LDL)
• Raises triglycerides
• Promotes fatty liver
• Contradicts the hypolipidemic effect of ginger

INTI — organic ginger + turmeric + black pepper, 1.19g sugar/100ml. Cardiovascular support without hepatic overload.